ZYDUSLIFE Zydus Lifesciences Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · F&O lot size: 900ZYDUSLIFE lot size: 900 shares per F&O lot for the 3 listed expiries (2026-10-27, 2026-11-23, 2026-12-29). One lot is worth about ₹10.03 lakh at the last underlying price of ₹1,113.89. All F&O lot sizes →
ZYDUSLIFE Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
ZYDUSLIFE Seasonality month by month since 2000 · adjusted month-end closes
ZYDUSLIFE in October: closed the month higher in 14 of 26 years (2000–2025), with a median move of +1.4% and an average of +0.8%.
Years the month closed higher / years with data, and the median monthly move. Past patterns, not a forecast: most months are close to a coin toss.
Live setups screens ZYDUSLIFE is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about ZYDUSLIFE
In the last completed session, Zydus Lifesciences Ltd. closed -1.37% with futures open interest moving +4.4%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.51, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,150 sits 3.2% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Zydus Lifesciences Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Zydus Lifesciences Ltd. leans cautious into the next session.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
ZYDUSLIFE Option Chain nearest expiry 2026-10-27 · spot 1,114 · EOD 2026-10-19
ZYDUSLIFE option chain today (2026-10-27 expiry, NSE data of 2026-10-19): put-call ratio 0.51 · max pain ₹1,150 · highest call OI at ₹1,200 · highest put OI at ₹1,200 · underlying ₹1,113.89. One lot is 900 shares. At-the-money implied volatility 24.9%, IV rank 44 and IV percentile 55 over the past year (range 14.5%–38.4%); 20-day historical volatility 24.1%.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 35%
Δ 0.98
θ -0.4
ν 0
|
1010 |
IV 35%
Δ -0.02
θ -0.2
ν 0
|
|
IV 33%
Δ 0.97
θ -0.4
ν 0
|
1020 |
IV 33%
Δ -0.03
θ -0.2
ν 0
|
|
IV 33%
Δ 0.96
θ -0.5
ν 0
|
1030 |
IV 33%
Δ -0.04
θ -0.3
ν 0
|
|
IV 31%
Δ 0.95
θ -0.6
ν 0
|
1040 |
IV 31%
Δ -0.05
θ -0.4
ν 0
|
|
IV 30%
Δ 0.92
θ -0.7
ν 0
|
1050 |
IV 30%
Δ -0.08
θ -0.5
ν 0
|
|
IV 29%
Δ 0.89
θ -0.8
ν 0
|
1060 |
IV 29%
Δ -0.11
θ -0.6
ν 0
|
|
IV 28%
Δ 0.85
θ -0.9
ν 0
|
1070 |
IV 28%
Δ -0.15
θ -0.7
ν 0
|
|
IV 28%
Δ 0.80
θ -1.0
ν 0
|
1080 |
IV 28%
Δ -0.20
θ -0.8
ν 0
|
|
IV 27%
Δ 0.72
θ -1.1
ν 1
|
1090 |
IV 27%
Δ -0.28
θ -0.9
ν 1
|
|
IV 27%
Δ 0.64
θ -1.2
ν 1
|
1100 |
IV 27%
Δ -0.36
θ -1.0
ν 1
|
|
IV 27%
Δ 0.54
θ -1.3
ν 1
|
1110 |
IV 27%
Δ -0.46
θ -1.1
ν 1
|
|
IV 28%
Δ 0.45
θ -1.3
ν 1
|
1120 |
IV 28%
Δ -0.55
θ -1.1
ν 1
|
|
IV 28%
Δ 0.36
θ -1.2
ν 1
|
1130 |
IV 28%
Δ -0.64
θ -1.0
ν 1
|
|
IV 28%
Δ 0.28
θ -1.1
ν 1
|
1140 |
IV 28%
Δ -0.72
θ -0.9
ν 1
|
|
IV 29%
Δ 0.22
θ -1.0
ν 0
|
1150 MP |
IV 29%
Δ -0.78
θ -0.8
ν 0
|
|
IV 30%
Δ 0.17
θ -0.8
ν 0
|
1160 |
IV 30%
Δ -0.83
θ -0.6
ν 0
|
|
IV 31%
Δ 0.13
θ -0.7
ν 0
|
1170 |
IV 31%
Δ -0.87
θ -0.5
ν 0
|
|
IV 32%
Δ 0.10
θ -0.6
ν 0
|
1180 |
IV 32%
Δ -0.90
θ -0.4
ν 0
|
|
IV 33%
Δ 0.08
θ -0.5
ν 0
|
1190 |
IV 33%
Δ -0.92
θ -0.3
ν 0
|
|
IV 34%
Δ 0.06
θ -0.5
ν 0
|
1200 R S |
IV 34%
Δ -0.94
θ -0.3
ν 0
|
|
IV 36%
Δ 0.05
θ -0.4
ν 0
|
1210 |
IV 36%
Δ -0.95
θ -0.2
ν 0
|
Chain Interpretation
Strategy Builder multi-leg payoff for ZYDUSLIFE options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
ZYDUSLIFE — frequently asked questions
What is the Zydus Lifesciences Ltd. share price today?
ZYDUSLIFE is trading at ₹1,113.90 (+0.00% vs previous close), per the latest update on this page.
What is the P/E ratio of Zydus Lifesciences Ltd.?
ZYDUSLIFE (Zydus Lifesciences Ltd.) has a trailing twelve-month P/E ratio of 24.8.
What is the market cap of Zydus Lifesciences Ltd.?
ZYDUSLIFE has a market capitalisation of approximately ₹111,112 crore.
Is ZYDUSLIFE near its 52-week high?
ZYDUSLIFE is trading -9.6% from its 52-week high of ₹1,232.10 as of 2026-10-19.
What is the RSI of ZYDUSLIFE?
The 14-day RSI of ZYDUSLIFE is 42.5, which is considered neutral.
Is ZYDUSLIFE above its 200-day moving average?
ZYDUSLIFE is trading above its 200-DMA of ₹1,026.79 (+8.5% away).
What is the F&O buildup in ZYDUSLIFE?
The latest end-of-day derivatives data classifies ZYDUSLIFE as Short Buildup (bias: bearish), based on the day's combined price and open-interest change.
What is the max pain and PCR for ZYDUSLIFE options?
ZYDUSLIFE's option-chain max pain strike is ₹1,150 and its put-call ratio (OI) is 0.51, from the latest end-of-day option chain.
Are FIIs or big investors buying ZYDUSLIFE?
Strota tracks every bulk and block deal in ZYDUSLIFE with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.